Parkinson’s disease, Alzheimer’s disease, Lewy Body Dementia – neurological conditions that affect people as they age are often as difficult to distinguish and diagnose as they are to treat. One San Diego diagnostics company is looking to change that with a unique test that may be able to identify certain diseases before they even manifest symptoms...READ MORE
A pioneer in the science of detecting misfolded proteins, Amprion advances the diagnosis of brain disorders. Our SAAmplify™-ɑSYN Test aids physicians in diagnosing Parkinson’s, Lewy body dementia, and Alzheimer’s with Lewy body variant. We plan to launch more biomarker tests in the future.
Our flagship α-synuclein SAA, SYNTap®, is getting a makeover.
Effective September 9, 2024, SYNTap will be
And stay tuned for the SAAmplify family of panels, coming soon!
